Skip to main content
logo
CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.41
-0.05 (-0.92%)
At close: Jul 15, 2025, 4:00 PM
5.42
+0.01 (0.18%)
After-hours: Jul 15, 2025, 4:00 PM EDT

CureVac Revenue

CureVac had revenue of 893.00K EUR in the quarter ending March 31, 2025, a decrease of -92.78%. This brings the company's revenue in the last twelve months to 523.70M, up 787.60% year-over-year. In the year 2024, CureVac had annual revenue of 535.18M with 895.54% growth.

Revenue (ttm)
523.70M EUR
Revenue Growth
+787.60%
P/S Ratio
2.17
Revenue / Employee
532,757 EUR
Employees
983
Market Cap
1.22B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 535.18M 481.42M 895.54%
Dec 31, 2023 53.76M -13.66M -20.26%
Dec 31, 2022 67.42M -35.57M -34.54%
Dec 31, 2021 102.99M 54.12M 110.74%
Dec 31, 2020 48.87M 31.46M 180.61%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

CVAC News

More News